Tortoise Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Tortoise Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-168	Closed	-$5.58K	–	796
2022 Q4	$5.58K	Hold	168	–	–	﹤0.01%	600
2022 Q3	$5K	Hold	168	–	–	﹤0.01%	613
2022 Q2	$5K	Hold	168	–	–	﹤0.01%	600
2022 Q1	$4K	Hold	168	–	–	﹤0.01%	605
2021 Q4	$3K	Buy	+168	New	+$3.22K	﹤0.01%	605

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tortoise Investment Management's VIVO Position: Q1 2023 in Review

Tortoise Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 168 shares — an estimated $5.58K sold.

Tortoise Investment Management first reported a position in VIVO in Q4 2021 and held it in 5 quarters. The position peaked at $5.58K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Tortoise Investment Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Tortoise Investment Management sold 168 Meridian Bioscience Inc shares in Q1 2023, an estimated $5.58K.
Tortoise Investment Management first reported a position in Meridian Bioscience Inc in Q4 2021 and held it in 5 quarters.
Tortoise Investment Management's Meridian Bioscience Inc position peaked at $5.58K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Tortoise Investment Management's 13F filing for Q1 2023, filed 9 May 2023.